Sponsor:
N-Power Medicine
Code:
NCT06877884
Conditions
Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Cancer
Study ID
NCT06877884
Start date
Aug 1, 2022
Status verified date
Oct, 2025
Completion date
Jan, 2099
Anticipated
Primary completion date
Jan, 2099
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Enrollment
20000 participants
Anticipated
Primary outcome measure
Central contacts
Locations
Pacific Cancer Care
Recruiting
Monterey, California, United States, 93940
Contacts
Registry Help Line
833-4NPM-REGBayhealth Cancer Center-Kent
Recruiting
Dover, Delaware, United States, 19901
Contacts
Principal Investigator:
Iftekar Khan, MD
Bayhealth Cancer Center- Sussex
Recruiting
Milford, Delaware, United States, 19963
Contacts
Principal Investigator:
Iftekar Kahn, MD
Northwest Oncology & Hematology
Recruiting
Elk Grove Village, Illinois, United States, 60007
Contacts
Registry Help Line, 833-4NPM-REG
support@npowermedicine.comNew Mexico Oncology Hematology Consultants
Recruiting
Albuquerque, New Mexico, United States, 87109
Contacts
Lankenau Medical Center
Recruiting
Paoli, Pennsylvania, United States, 19301
Contacts
Principal Investigator:
Paul Gilman, MD
Oncology Consultants, P.A.
Recruiting
Houston, Texas, United States, 77030
Contacts
Sponsor
N-Power Medicine
Last update posted
Oct 20, 2025
Last verified
Oct, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by N-Power Medicine on 2025-10-20.